NASDAQ:VIVE
Viveve Medical Inc Stock News
$0.0002
+0 (+0%)
At Close: Apr 17, 2024
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript
11:45pm, Thursday, 13'th May 2021
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript
Recap: Viveve Medical Q1 Earnings
05:15pm, Thursday, 13'th May 2021
Shares of Viveve Medical (NASDAQ:VIVE) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 2.44% year over year to ($0.80), which mis
Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update
04:02pm, Thursday, 13'th May 2021
Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets
Viveve Announces Adjournment of Annual Meeting
12:30pm, Tuesday, 11'th May 2021
Meeting scheduled to reconvene June 2, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / May 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE),
Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update
08:28am, Thursday, 06'th May 2021
ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
08:28am, Thursday, 01'st Apr 2021
ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Taiwan Intellectual Property
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2020 Results - Earnings Call Transcript
10:38pm, Thursday, 18'th Mar 2021
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2020 Results - Earnings Call Transcript
Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update
04:02pm, Thursday, 18'th Mar 2021
Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Vi
Huge Upside Potential in 5 Stocks Trading Under $10
06:25am, Saturday, 30'th Jan 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
2 Falling Knives to Catch
10:30am, Friday, 15'th Jan 2021
Wall Street recommends buying shares of CHF Solutions Inc (NASDAQ:CHFS) and Viveve Medical Inc (NASDAQ:VIVE), which sounds quite unexpected since these two stocks performed very poorly over the prior
Viveve Announces Pricing of Upsized $24 Million Underwritten Public Offering
08:30am, Thursday, 14'th Jan 2021
ENGLEWOOD, CO / ACCESSWIRE / January 14, 2021 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced the pricing of an upsiz
Viveve Medical's (VIVE) CEO Scott Durbin on Q3 2020 Results - Earnings Call Transcript
07:21pm, Thursday, 12'th Nov 2020
Viveve Medical's (VIVE) CEO Scott Durbin on Q3 2020 Results - Earnings Call Transcript
